Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.
about
Ligustrazine monomer against cerebral ischemia/reperfusion injuryPathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal modelsMultiplex Brain Proteomic Analysis Revealed the Molecular Therapeutic Effects of Buyang Huanwu Decoction on Cerebral Ischemic Stroke MiceThe immunology of stroke: from mechanisms to translationMicroglial cells contribute to endogenous brain defenses after acute neonatal focal strokePoly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signalingTargeting microglial activation in stroke therapy: pharmacological tools and gender effects.CD36 deletion improves recovery from spinal cord injury.CD36 participates in PrP(106-126)-induced activation of microglia.Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia.Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury.Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal stroke.Cellular origin and regulation of D- and L-serine in in vitro and in vivo models of cerebral ischemia.Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke.Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injuryCleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearanceCentral cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusionThe HMGB1 receptor RAGE mediates ischemic brain damage.Endothelial CD36 Contributes to Postischemic Brain Injury by Promoting Neutrophil Activation via CSF3.Genetic deletion of CD36 enhances injury after acute neonatal strokeBlood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat.Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signalingNF-κB and innate immunity in ischemic stroke.Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion ratsProgranulin deficiency promotes post-ischemic blood-brain barrier disruptionCD36: a multi-modal target for acute stroke therapy.Unique mechanisms of sheng yu decoction ( shèng yù tang) on ischemic stroke mice revealed by an integrated neurofunctional and transcriptome analysis.Lipoprotein receptor-related protein-6 protects the brain from ischemic injuryToll-like receptors: new players in myocardial ischemia/reperfusion injury.Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease.Peroxiredoxin sets the brain on fire after stroke.Microglia and Monocyte-Derived Macrophages in StrokeBrain dendritic cells in ischemic stroke: time course, activation state, and origin.Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage.Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in miceThe scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production.Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.Sulfosuccinimidyl oleate sodium is neuroprotective and alleviates stroke-induced neuroinflammation.
P2860
Q26862626-2F9971CF-FFB0-46FC-8A97-3CDD3F99094EQ27000069-C0850D2C-BB3D-4B73-8E2B-4325D64F5E8CQ28550456-F66725C4-85B4-4ACE-9A5A-8CBB83183505Q29620066-42D5EEC7-9CE7-4C98-B67E-F81DEAAAE1CAQ30422954-484A8680-D505-4A2A-BD6C-40F9C839349DQ33578933-EB7E4F41-6FC6-405D-B0C5-EC12ED8A397FQ33824991-D437B22C-F235-4F89-8ED8-46BA865E07F6Q33862217-05E09BFB-81F7-49EF-85F7-A4A5327A77F9Q34146362-3564A2CF-1655-4D82-BDD3-DCCCDBD17FA8Q34177008-B2CD9FD6-5FFB-4E7E-B170-55C7A3288145Q34410332-1F7338D8-7661-4946-9938-A1383D7714D2Q34598220-6F622F77-37E5-42F4-871B-28BDADC8D767Q34727367-BF4745C4-7573-4F56-A1E6-B7221EEE721DQ35086740-4E0180FE-4467-4622-96AB-5E44472D1FC9Q35142653-023BF2A4-D666-4D8E-A77E-2CBBCAFD6466Q35181594-535BC2C4-64F7-4F9D-97EC-38A7A47A6C99Q35895324-6EFB4733-F492-4510-AB2F-BF1889135127Q36048230-1DFF0F42-F8CF-4DF5-A8E9-F4EE197B8A73Q36113521-53588DAB-13FA-46D6-AD22-5380086E66BFQ36134557-6A412E6F-7046-4D30-9C09-E2FBF61CAE7AQ36254055-D3779BF2-7874-4C37-94A0-6B97A40047E0Q36515336-51D9CD7A-E831-4A41-89C7-DAAEA5BD34DFQ36517224-EF12AA1E-6922-4FD5-A747-8856E57CED04Q36534341-4809C85F-6514-4292-9F1C-0568BDF1B94CQ37252167-A855BC5F-D8BE-4EE4-856B-AD5E517DD57FQ37307976-9E86D9C0-2BA7-40AA-BBA6-9891E21917CFQ37381816-0FF53D26-FC44-4D6B-9748-F26EF55B3079Q37459051-40C8FE19-D412-4D7D-B949-E0EBB03ACE85Q37585357-4689FF80-FFBE-49DC-A88C-91FB28E3EA82Q37601648-5E9D3F20-E0FB-44D1-B8B9-DD34C840FC0AQ37810952-DD563BD9-D3CC-415A-9AFB-B070A1F2B4DBQ38112107-EDD44791-C970-4DE3-BEAB-7D0B6DF56689Q38287139-370DBA92-4D80-4DF1-A276-9B2A3B51322CQ38916635-80A2F08A-1B4A-4CD4-AC56-1D707477B815Q41063596-26121240-E18C-46DB-8E30-AA01CADEFAA0Q41475535-D21A8115-79D7-4D6A-B92F-EC7FF5062AA2Q42280421-02AD136D-7683-444F-BA71-1CA70AE8C549Q42719584-0A08BCC8-B2B5-463A-9E1A-6C32132BBE8FQ43072176-6EC31E70-5D5B-42C8-B380-958FDCF952A3Q47110128-882965BA-B9A1-4B28-B748-D8322E93A30B
P2860
Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Nuclear factor-kappaB activati ...... dle cerebral artery occlusion.
@en
type
label
Nuclear factor-kappaB activati ...... dle cerebral artery occlusion.
@en
prefLabel
Nuclear factor-kappaB activati ...... dle cerebral artery occlusion.
@en
P2093
P2860
P1476
Nuclear factor-kappaB activati ...... dle cerebral artery occlusion.
@en
P2093
Alexander Kunz
Gianfranco Racchumi
Karin Hochrainer
Munehisa Shimamura
Takato Abe
P2860
P304
P356
10.1523/JNEUROSCI.5205-07.2008
P407
P577
2008-02-01T00:00:00Z